Later studies showed that passive immunization of Apoe−/− mice with monoclonal T15 antibody resulted in significant reductions in the development of vein-graft atherosclerosis without altering serum cholesterol levels (81), establishing the potential efficacy of NAb-based therapies as a treatment for ASCVD. The gene discussed is APOE; the disease is atherosclerosis.